ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Código da empresaRSLS
EmpresaReShape Lifesciences Inc
CEOMr. Paul F. Hickey
Sitehttps://www.reshapelifesciences.com/obalon/
Perguntas frequentes
Qual é o preço atual de ReShape Lifesciences Inc (RSLS)?
O preço atual de ReShape Lifesciences Inc (RSLS) é 3.920.
Qual é o símbolo de ReShape Lifesciences Inc?
O símbolo de ReShape Lifesciences Inc é RSLS.
Qual é o valor máximo em 52 semanas de ReShape Lifesciences Inc?
A máxima de 52 semanas de ReShape Lifesciences Inc é 303.248.
Qual é o valor mínimo em 52 semanas de ReShape Lifesciences Inc?
A mínima de 52 semanas de ReShape Lifesciences Inc é 1.870.
Qual é o valor de mercado de ReShape Lifesciences Inc?
O valor de mercado de ReShape Lifesciences Inc é 10.29M.
Qual é o lucro líquido de ReShape Lifesciences Inc?
O lucro líquido de ReShape Lifesciences Inc é -7.13M.
Atualmente, ReShape Lifesciences Inc (RSLS) está classificada como Comprar, Manter ou Vender?
De acordo com analistas, a ReShape Lifesciences Inc (RSLS) possui uma classificação geral de --, com preço-alvo de --.
Qual é o lucro por ação (EPS TTM) de ReShape Lifesciences Inc (RSLS)?
O lucro por ação (EPS TTM) de ReShape Lifesciences Inc (RSLS) é -6.068.